OGN News & Events

In light of the pending merger, Organon will not be providing financial guidance or hosting quarterly earnings calls.

Reports Q1 revenue $1.46B, consensus $1.49B.

Organon canceled its first quarter 2026 earnings conference call previously scheduled for May 7, 2026. The cancellation is the result of the company's April 26, 2026 announcement that it has entered into an agreement under which Sun Pharmaceutical Industries Limited will acquire Organon. Organon will issue its first quarter financial results on April 30, 2026 in a press release, as well as in a subsequent Form 10-Q that it will file with the U.S. Securities and Exchange Commission.